TRLS logo

Trellus Health plc Stock Price

AIM:TRLS Community·UK£1.0m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

TRLS Share Price Performance

UK£0.0065
-0.00 (-3.70%)
UK£0.0065
-0.00 (-3.70%)
Price UK£0.0065

TRLS Community Narratives

There are no narratives available yet.

Snowflake Analysis

Moderate risk with adequate balance sheet.

5 Risks
0 Rewards

Trellus Health plc Key Details

US$359.0k

Revenue

US$0

Cost of Revenue

US$359.0k

Gross Profit

US$7.2m

Other Expenses

-US$6.9m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-0.043
100.00%
-1,918.66%
0%
View Full Analysis

About TRLS

Founded
2020
Employees
18
CEO
Marla Dubinsky
WebsiteView website
www.trellushealth.com

Trellus Health plc provides digital chronic condition management solutions for employers and health plans. The company offers GRITT resilience-based methodology; and TrellusElevate, a proprietary HIPAA-compliant technology platform for remote telemedicine care. Its platform provides support for managing inflammatory bowel disease (IBD), including Crohn's Disease and ulcerative colitis. The company was incorporated in 2020 and is headquartered in White Plains, New York.

Recent TRLS News & Updates

Recent updates

No updates